Antidepressants: Brand name or generic?

Psychiatric Times

Volumn 26, Issue 5, 2009, Pages 26-32

  Jefferson, James W ^a  

^a UNIVERSITY OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649947880     PISSN: 08932905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Elliott G. Basics of US patents and the patent system. AAPS J. 2007;9:E317-E324.
2. Swann JP. U.S. History of the FDA. U.S. Food and Drug Administration, http://www.fda.gov/oc/history/ historyoffda/default.htm. Accessed March 11,2009.
3. Frank RG. Regulation of follow-on biologies. NEngl J Med. 2007;357:841-843.
4. Frank RG.The ongoing regulation of generic drugs. N Engl J Med. 2007;357:1993-1996.
5. Glover GJ.The influence of market exclusivity on drug availability and medical innovations. ASPS J. 2007;9:E312-E316.
6. Huskamp HA. Prices, profits and innovations: examining criticisms of new psychotropic drugs' value. Health Aff (Millwood). 2006;25:635-646.
7. Kesselheim AS. Intellectual property policy in the pharmaceutical sciences: the effect of inappropriate patents and market exclusivity extensions on the health care system. AAPS J. 2007;9:E306-E311.
8. Center for Drug Evaluation and Research. 180-Day generic drug exclusivity. U.S. Food and Drug Administration. http://www.fda.gov/CDER/about/ smallbiz/ generic-exclusivity.htm. Updated September 13, 2001. Accessed March 11,2009.
9. Center for Drug Evaluation and Research. Generic drugs: questions and answers. U.S. Food and Drug Administration, http://www.fda.gov/buyonlineguide/ generics-q&a.htm. Published July 31,2002. Accessed March 11,2009.
10. U.S. Department of Health and Human Services. Approved drug products with therapeutic equivalence evaluations. 29th ed. 2009. http://www.fda.gov/cder/ orange/obannual.pdf. Accessed March 11,2009.
11. Meyer MC. United Stated Food and Drug Administration requirements for approval of generic drug products. J Clin Psychiatry. 2001 ;62(suppl 5):4-9.
12. New venlafaxine extended-release formulation. Pharmacist's Letter/Prescriber's Letter. 2009;25: 250108.
13. 13.30 Ranbaxy generic drugs banned by FDA. NEWS- Infemo. September 17,2008. http/www.newsinfemo. com/archives/3838. Accessed March 11,2009.
14. Borgheini G.The bioequivalence and therapeutic efficacy of generic versus brand-name psychoactive drugs. Clin Then 2003;25:1578-1592.
15. Kumet R, Gelenberg AJ. The effectiveness of generic agents in psychopharmacologic treatment. Essent Psychopharmacol. 2005;6:104-111.
16. Shields BJ, Nahata MC. Efficacy of brand-name vs. generic fluoxetine. PerspectPsychiatrCare. 2003; 39:122,135.
17. Bakish D, Miller C, Hooper CL, et al. A double- blind, crossover study comparing generic and brand fluoxetine in the treatment of major depressive disorder. Poster presented at 40th Annual Meeting of National Institute of Mental Health, New Clinical Drug Evaluation Unit (NCDEU); May 30-June 2,2000; Boca Raton, FL.
18. Van Ameringen M, Mancini C, Patterson B, Bennett M. Symptom relapse following switch from Celexa to generic citalopram: an anxiety disorders case series. J Psychopharmacol. 2007;21:472-476.
19. Rosenthal J, Kong B, Jacobs L, Katzman M. Did a switch to a generic antidepressant cause relapse? J Fam Pract 2008;57:109-114.
20. Mayo JL, Cahill GM, Lott RS. Conversion from sustained-release to immediate-release bupropion: patient tolerability and economic impact. Pharmacotherapy. 2005;25:520-525.
21. The People's Pharmacy With Joe andTerry Grae- don. Generic antidepressant raises questions. July 16, 2007. http://www.peoplespharmacy.com/archives/ print/generic-antidepressant-raises-questions.asp. Accessed March 11,2009.
22. The People's Pharmacy With Joe and Terry Graedon. Generic drug equality questioned, http:// www. peoplespharmacy.com/archives/generic- drug-problems/genericjlrug-equality-questioned. php?page=8. Accessed March 11,2009.
23. Stenson J. Report questions generic antidepressant: ConsumerLab.com finds cheaper drug may not work the same as brand. October 12, 2007. httpwvw.msnbc.msn.com/id/21142869.Accessed March 11,2009.
24. Center for Drug Evaluation and Research. Review of therapeutic equivalence: generic bupropion XL 300 mg and Wellbutrin XL 300 mg. U.S. Food and Drug Administration, http://www.fda.gov/cder/drug/infopage/ bupropion/TE-review.htm. Published April 16,2008. Accessed March 11,2009.
25. Wellbutrin versus generic bupropion. Med Lett Drugs Ther. 2008;50:54-55.
26. Georgiades A. Wellbutrin generic faces study. Wall Street Journal. September 23,2008:B6.